Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Anika Therapeutics Inc ANIK

Anika Therapeutics, Inc. is a global joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, and sports medicine. It is focused on developing, manufacturing and commercializing products on its hyaluronic acid (HA), technology platform. Its OA Pain... see more

NDAQ:ANIK - Post Discussion

Anika Therapeutics Inc > Facial Injectables Market Share, Size, Report Analysis 2026
View:
Post by zayaroy18 on Jun 09, 2021 7:51am

Facial Injectables Market Share, Size, Report Analysis 2026

According to the latest report by IMARC Group, titled “Facial Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global facial injectables market is expected to grow at a CAGR of around 11% during the forecast period (2021-2026).

Facial injectables, or derma fillers, are gel-like synthetic or naturally occurring substances injected in the folds, lines, and tissues of the face for cosmetic and therapeutic procedures. They are used for enhancing facial contours, plumping cheeks and lips, correcting acne scars and minimizing the visibility of smile lines. Some commonly used facial injectables include collagen, hyaluronic acid and calcium hydroxyl fillers. In comparison to plastic surgeries, they are usually absorbable and can be altered to provide permanent or temporary results based on the requirement of the consumer.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Facial Injectables Market Trends:

The global facial injectables market is primarily driven by the increasing consciousness among the masses regarding physical appearance and the rising preference for minimally invasive (MI) cosmetic procedures. Moreover, the widespread adoption of hyaluronic acid as a natural filler to maintain healthy moisture levels and reverse skin damage is providing a thrust to the market growth. Product manufacturers are also developing innovative wrinkle relaxers and fillers with lower risks of infections, minimal blood loss and lesser recovery time. Other factors, including the rising geriatric population and increasing expenditure capacities of the consumers, are anticipated to drive the market toward growth.

Request Free Sample Report:
https://www.imarcgroup.com/facial-injectables-market/requestsample

Facial Injectables Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Allergan Plc
  • Anika Therapeutics Inc.
  • Bloomage BioTechnology
  • Johnson & Johnson
  • Galderma Pharma S.A.
  • Integra LifeSciences
  • Ipsen (Mayroy SA)
  • Medytox Inc.
  • Merz Holding GmbH & Co. KG
  • Prollenium Medical Technologies Inc.
  • Sanofi
  • SciVision Biotech Inc.
  • Sinclair Pharma (Huadong Medicine Co. Ltd.)
  • Suneva Medical Inc.
  • Bausch Health Companies Inc.

The report has segmented the market on the basis on region, product type, application type, application and end user.

Breakup by Product Type:

  • Collagen
  • Hyaluronic Acid (HA)
  • Botulinum Toxin Type A
  • Calcium Hydroxylapatite (CaHA)
  • Polymethylmethacrylate Beads (PMMA Microspheres)
  • Poly-L-Lactic Acid (PLLA)
  • Others

Breakup by Application Type:

  • Aesthetics
  • Therapeutics

Breakup by Application:

  • Facial Line Correction
  • Lip Augmentation
  • Face Lift
  • Acne Scar Treatment
  • Others

Breakup by End User:

  • Hospitals
  • Dermatology Clinics
  • Others

Breakup by Region:

  • North America: United States, Canada
  • Asia Pacific: China, Japan, India, South Korea, Australia, Indonesia, Others
  • Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Others
  • Latin America: Brazil, Mexico, Other
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/facial-injectables-market

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2015-2020)
  • Market Outlook (2021- 2026)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities